• Users Online: 215
  • Print this page
  • Email this page

 Table of Contents  
Year : 2021  |  Volume : 11  |  Issue : 4  |  Page : 425-426

The spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad

Klinik Landstrasse, Messerli Institute, Vienna, Austria

Date of Submission30-Mar-2021
Date of Acceptance27-Apr-2021
Date of Web Publication16-Jul-2021

Correspondence Address:
Prof. Josef Finsterer
Postfach 20, 1180 Vienna
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjo.tjo_18_21

Rights and Permissions

How to cite this article:
Finsterer J. The spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad. Taiwan J Ophthalmol 2021;11:425-6

How to cite this URL:
Finsterer J. The spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad. Taiwan J Ophthalmol [serial online] 2021 [cited 2023 Mar 23];11:425-6. Available from: https://www.e-tjo.org/text.asp?2021/11/4/425/321676

With interest we read the article by Lock et al. about the neuro-ophthalmologic involvement in mitochondrial disorders (MIDs).[1] Neuro-ophthalmologic abnormalities addressed in the review were progressive external ophthalmoplegia (PEO) with or without ptosis, cataract, macula pattern dystrophy, pigmentary retinopathy, optic neuropathy, and retro-chiasmal visual loss.[1] It was concluded that the treatment of ophthalmologic involvement in MIDs is largely supportive and symptomatic, but that this will likely change over the coming years and is already occurring in the realms of family planning.[1] The study is appealing but raises the following comments and concerns.

We do not agree with the notion that cataract is not a prominent feature of MIDs.[1] On the contrary, cataract is a striking feature of MIDs and has been reported in syndromic and nonsyndromic MIDs. Among the syndromic MIDs, cataract has been reported in MELAS, Leigh syndrome,[2] Kearns-Sayre syndrome (KSS),[3] autosomal dominant optic atrophy (ADOA), Wolfram syndrome, Leber's hereditary optic neuropathy (LHON), myoclonic epilepsy with ragged-red fibers syndrome, mitochondrial diabetes and deafness (MIDD), and PEO.[4] Cataract has been also reported in several nonsyndromic MIDS.[5]

Another ophthalmologic manifestation of MIDs not extensively discussed is glaucoma.[4] Glaucoma has been reported in MELAS, KSS, LHON, ADOA, myo-neuro-gastro-intestinal encephalopathy (MNGIE), Wolfram syndrome, pontocerebellar hypoplasia (PCH),[4] and several nonsyndromic MIDs.

A further neuro-ophthalmologic manifestation of MIDs not discussed is migraine. Migraine or migraine-like headache is a common manifestation of various syndromic and nonsyndromic MIDs, such as MELAS, MNGIE, or KSS.[6] Particularly in patients with auravisual phenomena, such as scotoma, can migraine be a dominant feature.

Another neuro-ophthalmologic abnormality not addressed in the review is nystagmus. Since cerebral involvement, including the cerebellum, is common in MIDs, several of the syndromic but also nonsyndromic MIDs present with nystagmus. Among the syndromic MIDs, nystagmus has been reported in Leigh syndrome, Alpers-Huttenlocher disease, LHON, MELAS, and ADOA.[4]

There is no mentioning of choroideal atrophy as has been reported in MELAS, MIDD, Mohr-Tranebjaerg syndrome, and nonsyndromic MIDs.[4] Keratoconus has been particularly reported in nonsyndromic MIDs.[4] Patients with PCH may present with a megaloconrea.[4] Iris atrophy has been found in patients with MELAS.[4] Whether pupillary dysfunction in LHON or nonsyndromic MIDs is due to involvement of the autonomic nervous system or due to involvement of the sphincter pupillae muscles remains speculative.

Overall, the review highlights important neuro-ophthalmologic manifestations of MIDs but does not cover the entire spectrum of neuro-ophthalmologic disease in MIDs. Missing are glaucoma, nystagmus, migraine, choroideal atrophy, megalocornea, pupillary dysfunction, and keratoconus.

Financial support and sponsorship


Conflicts of interest

The authors declare that there are no conflicts of interests of this paper.

  References Top

Lock JH, Irani NK, Newman NJ. Neuro-ophthalmic manifestations of mitochondrial disorders and their management. Taiwan J Ophthalmol 2021;11:39-52.  Back to cited text no. 1
  [Full text]  
Moosa S, Haagerup A, Gregersen PA, Petersen KK, Altmüller J, Thiele H, et al. Confirmation of CAGSSS syndrome as a distinct entity in a Danish patient with a novel homozygous mutation in IARS2. Am J Med Genet A 2017;173:1102-8.  Back to cited text no. 2
Phadke M, Lokeshwar MR, Bhutada S, Tampi C, Saxena R, Kohli S, et al. Kearns Sayre Syndrome–Case report with review of literature. Indian J Pediatr 2012;79:650-4.  Back to cited text no. 3
Finsterer J, Zarrouk-Mahjoub S, Daruich A. The eye on mitochondrial disorders. J Child Neurol 2016;31:652-62.  Back to cited text no. 4
Jaksch M, Lochmuller H, Schmitt F, Volpel B, Obermaier-Kusser B, Horvath R. A mutation in mt tRNALeu (UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology 2001;57:1930-1.  Back to cited text no. 5
Vollono C, Primiano G, Della Marca G, Losurdo A, Servidei S. Migraine in mitochondrial disorders: Prevalence and characteristics. Cephalalgia 2018;38:1093-106.  Back to cited text no. 6


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded191    
    Comments [Add]    

Recommend this journal